Table 1.

Demographic, clinical and laboratory data at the admission in ICU (T0)

	Standard nutrition (N = 15)	Specialized nutrition (N = 16)	p-value
Sex (M: F)	11: 4	13: 3	0.433
Age (Years)	56 ± 22	51 ± 22	0.56
GCS	7 [7, 8]	7 [6.75–7.25]	0.69
BMI (Kg/m2)	25.3 ± 4.3	24.5 ± 3	0.56
mNUTRIC score	6 [4–6.5]	4 [3–5.25]	0.34
APACHE II score	20 [18–23]	17.5 [13.75–23]	0.28
SAPS II score	53 [49–58.5]	46.5 [40–59.25]	0.22
Albumin (g/dl)	3.48 ± 0.66	3.22 ± 1.1	0.94
Proteins (g/dl)	5.41 ± 0.5	5.63 ± 1.2	0.48
White blood cells (10^3/mcl)	13.5 ± 3.7	12 ± 4.7	0.57
Procalcitonin (ng/ml)	0.5 ± 1	0.2 ± 0.6	0.31
Platelets (10^3/mcl)	214.2 ± 70.2	196.37 ± 83.7	0.37
Platelet distribution width (fL)	12.3 ± 1.8	13.6 ± 3.1	0.16
Mean platelet volume (fL)	10.7 ± 0.8	11.1 ± 1.4	0.26
Plateletcrit (%)	0.2 ± 0.006	0.2 ± 0.007	0.22
Creatinine (mg/dl)	1.5 ± 1.8	1.6 ± 2	0.22
Vasopressor use, N(%)	10 (67%)	12 (75%)	0.43
smokers,N(%)	4 (26%)	7 (43%)	0.10
Marshall score	2 [2, 3]	2.5 [2, 3]	0.59
Comorbidities
Neurological	5 (33%)	3 (19%)	0.19
Cardiovascular	9 (60%)	6 (37%)	0.05
Diabetes	2 (13%)	0 (0%)	0.10
Respiratory	2 (13%)	1 (6%)	0.36
Empiric cephalosporin treatment at T7, N (%)	7 (47%)	5 (31%)	0.19

Data were expressed as mean ± SD, median [25–75th percentile] or %